Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigine

International Journal of Neuropsychopharmacology

Volumn 14, Issue 8, 2011, Pages 1091-1098

  Li, Nanxin ^a,b   He, Xiaolu ^b   Zhang, Yu ^b   Qi, Xiaoli ^c   Li, Huijie ^c   Zhu, Xinhong ^d   He, Shuchang ^b  

^a YALE UNIVERSITY   (United States)

^b PEKING UNIVERSITY   (China)

^c INSTITUTE OF PSYCHOLOGY   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Antidepressant; BDNF; CUS; FST; lamotrigine; NSFT

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; LAMOTRIGINE;

ARTICLE; BIPOLAR DISORDER; CHRONIC UNPREDICTABLE STRESS; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FORCED SWIM TEST; FUNCTION TEST; HIPPOCAMPUS; MALE; NONHUMAN; NOVELTY SUPPRESSED FEEDING TEST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STRESS; SUCROSE PREFERENCE TEST; SWIMMING; UPREGULATION;

ANIMALS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKB; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; SWIMMING; TIME FACTORS; TRIAZINES;

EID: 80052961352     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710001082     Document Type: Article

References (25)

1. Ali A, Pillai KK, Pal SN (2003). Effects of folic acid and lamotrigine therapy in some rodent models of epilepsy and behaviour. Journal of Pharmacy and Pharmacology 55, 387-391. (Pubitemid 36410362)
2. Bourin M, Masse F, Hascoet M (2005). Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test. Journal of Psychiatry & Neuroscience 30, 275-282. (Pubitemid 41243295)
3. Bourin M, Prica C (2007). The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders. Neuroscience and Biobehavioral Reviews 31, 963-975. (Pubitemid 47285346)
4. Bowden CL, Mitchell P, Suppes T (1999). Lamotrigine in the treatment of bipolar depression. European Neuropsychopharmacology 9 (Suppl. 4), S113-S117. (Pubitemid 29397411)
5. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, et al. (1999). A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. Journal of Clinical Psychiatry 60, 79-88. (Pubitemid 29104383)
6. Calabrese JR, Shelton MD, Rapport DJ, Kujawa M, et al. (2001). Current research on rapid cycling bipolar disorder and its treatment. Journal of Affective Disorders 67, 241-255. (Pubitemid 34183356)
7. Chang YC, Rapoport SI, Rao JS (2009). Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex. Neurochemical Research 34, 536-541.
8. Consoni FT, Vital MA, Andreatini R (2006). Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test. European Neuropsychopharmacology 16, 451-458. (Pubitemid 43996884)
9. Duman RS (2004). Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Medicine 5, 11-25. (Pubitemid 38391953)
10. Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59, 1116-1127.
11. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, et al. (2003). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry 60, 804-815. (Pubitemid 36960912)
12. Garrido R, Springer JE, Hennig B, Toborek M (2003). Apoptosis of spinal cord neurons by preventing depletion nicotine attenuates arachidonic acid-induced of neurotrophic factors. Journal of Neurotrauma 20, 1201-1213. (Pubitemid 37467283)
13. Goodwin GM, Anderson I, Arango C, Bowden CL, et al. (2008). ECNP consensus meeting. Bipolar depression. Nice, March 2007. European Neuropsychopharmacology 18, 535-549.
14. Greene J, Banasr M, Lee B, Warner-Schmidt J, et al. (2009). Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology 34, 2459-2468.
15. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, et al. (2004). Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Molecular Psychiatry 9, 609-620, 544. (Pubitemid 38850441)
16. Li N, He X, Qi X, Zhang Y, et al. (2010). The mood stabilizer lamotrigine produces antidepressant behavioral effects in rats: role of brain-derived neurotrophic factor. Journal of Psychopharmacology. Published online: 1 February 2010. doi:10.1177/0269881109359102.
17. Nibuya M, Takahashi M, Russell DS, Duman RS (1999). Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neuroscience Letter 267, 81-84. (Pubitemid 29251591)
18. Prica C, Hascoet M, Bourin M (2008). Antidepressant-like effect of lamotrigine is reversed by veratrine: a possible role of sodium channels in bipolar depression. Behavioral Brain Research 191, 49-54.
19. Rao JS, Rapoport SI (2009). Mood-stabilizers target the brain arachidonic acid cascade. Current Molecular Pharmacology 2, 207-214.
20. Santarelli L, Saxe M, Gross C, Surget A, et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809. (Pubitemid 36962615)
21. Schmidt HD, Duman RS (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behavioural Pharmacology 18, 391-418. (Pubitemid 47356367)
22. Shirayama Y, Chen AC, Nakagawa S, Russell DS, et al. (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 22, 3251-3261. (Pubitemid 35379212)
23. Vigo DV, Baldessarini RJ (2009). Anticonvulsants in the treatment of major depressive disorder: an overview. Harvard Review of Psychiatry 17, 231-241.
24. Warner-Schmidt JL, Duman RS (2007). VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proceedings of the National Academy of Sciences USA 104, 4647-4652. (Pubitemid 47186279)
25. Willner P (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90-110. (Pubitemid 41160326)